| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.44 | 0.1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |